New Delhi, Sept. 17 -- The Ministry of Health and Family Welfare has issued a comprehensive advisory to all States and Union Territories regulating the use of stem cell therapy, directing that it can be offered as routine standard clinical care only for approved indications, in strict compliance with a recent Supreme Court verdict.

The directive, issued on September 16 to all states and UTs that have adopted the Clinical Establishments (Registration and Regulation) Act, 2010, comes in the wake of the Supreme Court's judgment delivered on January 30, 2026, in Yash Charitable Trust & Ors v Union of India & Ors.

According to a press release issued by the Ministry, the advisory reiterates the existing framework governing stem cell research ...